Trademark Details For IMOSIPA FUSA (Serial Number 98817999)

  •  Home
  •  Print
IMOSIPA FUSA
1
3
2
0
Serial Number  United States - USPTO 98817999
Registration Number -
Mark
IMOSIPA FUSA
Filing Date Oct-24-2024
Status
Pending  
FIRST EXTENS.. (730)
FIRST EXTENSION - GRANTED
Attorney Name
TTAB
0




005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLori Wolfe Teva Pharmaceuticals USA, Inc.
Address400 Interpace Parkway Parsippany, NJ 07054 United States

Prosecution History

DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-24-2024NEW APPLICATION ENTERED   NWAPI
Oct-24-2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Mar-24-2025ASSIGNED TO EXAMINER   DOCKD
Mar-31-2025APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Apr-23-2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Apr-29-2025PUBLISHED FOR OPPOSITION   PUBOA
Apr-29-2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jun-24-2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jan-21-2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED   REAPI
Jan-21-2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED   ARAAI
Jan-21-2026TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Jan-26-2026ABANDONMENT - NO USE STATEMENT FILED   ABN6S
Jan-26-2026ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED   MAB6E
Jan-26-2026TEAS PETITION TO REVIVE RECEIVED   PROAI
Jan-26-2026PETITION TO REVIVE-GRANTED   PETGO
Jan-26-2026NOTICE OF REVIVAL - E-MAILED   NREVE
Jan-26-2026SOU EXTENSION RECEIVED WITH TEAS PETITION   TPEXI
Mar-02-2026CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Dec-23-2025SOU EXTENSION 1 FILED   EXT1S
Mar-03-2026SOU EXTENSION 1 GRANTED   EX1GS
Mar-04-2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE